1st Counsel – Lifestyle
Author:
Caribou Biosciences, Inc.
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference
May 5, 2026
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
March 31, 2026
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 5, 2026